美國青光眼地圖冊 (2020年):Med / Op Index(TM) 目錄分析
2020 United States Glaucoma Atlas Featuring the Market Scope Exclusive MedOp Index Analysis
|出版商||Market Scope, LLC||商品編碼||924492|
|美國青光眼地圖冊 (2020年):Med / Op Index(TM) 目錄分析 2020 United States Glaucoma Atlas Featuring the Market Scope Exclusive MedOp Index Analysis|
|出版日期: 2020年02月11日||內容資訊: 英文||
本報告提供美國的青光眼市場調查，依據Med / Op Index™ 目錄，提供85大都會圈的青光眼人口的分佈，治療數量，外科醫生的技術引進趨勢，治療機會分析等彙整資料。
The US accounts for an estimated 6.1 percent of the global glaucoma population, but its glaucoma device market accounts for 63 percent of global revenue.
The United States Glaucoma Atlas, new in 2020, provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. The atlas identifies potential based on a variety of factors, which allows us to rank metros by opportunity and offers strategic insights into the top potential markets in the US.
Featured in the atlas is the Med/Op Index™ Analysis, a proprietary new index developed to estimate the market opportunity for each metropolitan area. This proprietary index identifies the potential based on patient demographics, procedure volumes, and surgeon adoption of technology - including MIGS.
The Glaucoma Atlas can be used to evaluate market potential, identify growth opportunities, and allocate sales resources.
Geographic opportunity is estimated with multi-factor criteria using Market Scope's MedOp Index™ Analysis. The index is derived from multiple supporting indexes and considers the following factors in each metro:
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience, and each data point is driven by a combination of sources, including the following: